CSIMarket
 


Immunic Inc   (IMUX)
Other Ticker:  
 
 

IMUX's Income from Cont. Operations Growth by Quarter and Year

Immunic Inc 's Income from Cont. Operations results by quarter and year




IMUX Income from Cont. Operations (in millions $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter December - -21.19 -11.16 -2.51
III Quarter September -21.22 -19.29 -12.91 -8.22
II Quarter June -21.90 -17.93 -11.46 -14.71
I Quarter March -20.81 -34.53 -8.49 -9.49
FY   -63.93 -92.94 -44.02 -34.93



IMUX Income from Cont. Operations third quarter 2022 Y/Y Growth Comment
Immunic Inc in the third quarter 2022 recorded loss from continued operations of $ -21.22 millions.

According to the results reported in the third quarter 2022, Immunic Inc achieved the best Income from Cont. Operations growth in Major Pharmaceutical Preparations industry. While Immunic Inc ' s Income from Cont. Operations no change of % ranks overall at the positon no. in the third quarter 2022.




IMUX Income from Cont. Operations ( Y/Y Growth %) 2022
2021 2020 2019
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Immunic Inc 's third quarter 2022 Income from Cont. Operations $ -21.22 millions IMUX's Income Statement
Immunic Inc 's third quarter 2021 Income from Cont. Operations $ -19.29 millions Quarterly IMUX's Income Statement
New: More IMUX's historic Income from Cont. Operations Growth >>


IMUX Income from Cont. Operations (Quarter on Quarter Growth %)

2022
2021 2020 2019
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Income from Cont. Operations third quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Income from Cont. Operations Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Income from Cont. Operations third quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Income from Cont. Operations Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Income from Cont. Operations by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Immunic Inc 's Q/Q Income from Cont. Operations Growth


Income from Cont. Operations Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


IMUX's III. Quarter Q/Q Income from Cont. Operations Comment
Even if Immunic Inc in the III. Quarter 2022 revealed loss from continued operations of $ -21.22 millions, some analyst said, that this are recovery in contrast to the -21.90 millions in the second quarter.

Within Major Pharmaceutical Preparations industry Immunic Inc achieved highest sequential Income from Cont. Operations growth. While Immunic Inc 's Income from Cont. Operations growth quarter on quarter, overall rank is .


Income from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Income from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Income from Cont. Operations Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


IMUX's III. Quarter Q/Q Income from Cont. Operations Comment
Even if Immunic Inc in the III. Quarter 2022 showed loss from continued operations of $ -21.22 millions, management point out, that those numbers show slight up side relative to the -21.90 millions in the second quarter.

Within Major Pharmaceutical Preparations industry Immunic Inc achieved highest sequential Income from Cont. Operations growth. While Immunic Inc 's Income from Cont. Operations growth quarter on quarter, overall rank is .


Immunic Inc 's 12 Months Income from Cont. Operations Growth Year on Year


Income from Cont. Operations TTM Growth

12 Months Ending
(Sep 30 2022)
12 Months Ending
(Jun 30 2022)
12 Months Ending
(Mar 31 2022)
12 Months Ending
(Dec 31 2021)
12 Months Ending
(Sep 30 2021)
Cumulative Income from Cont. Operations 12 Months Ending $ -85.12 $ -83.19 $ -79.22 $ -92.95 $ -82.92
Y / Y Income from Cont. Operations Growth (TTM) - - - - -
Year on Year Income from Cont. Operations Growth Overall Ranking # # # # #
Seqeuential Income from Cont. Operations Change (TTM) - - - - -
Seq. Income from Cont. Operations Growth (TTM) Overall Ranking # # # # #




Cumulative Income from Cont. Operations growth Comment
Immunic Inc ' has realized cumulative trailing twelve months loss from continued operations of $ -85 millions in the Sep 30 2022 period.
The situation is detiriorating as the cumulative loss from continued operations is getting bigger from $ -83.19 millions for the period from Jun 30 2022 to Sep 30 2021 and $ -21.9 millions for the twelve months ending in the quarter Sep 30 2021 Sofia Sousa mentioned.

Immunic Inc achieved highest trailing twelve month year on year Income from Cont. Operations growth. While overall Income from Cont. Operations growth ranking, remained unchanged compare to the previous quarter at no. .

Income from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Income from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Income from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Income from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Income from Cont. Operations growth Comment
Immunic Inc ' has realized cumulative trailing twelve months loss from continued operations of $ -85 millions in the Sep 30 2022 period.
The business is detiriorating as the cumulative loss from continued operations is getting bigger from $ -83.19 millions for the period from Jun 30 2022 to Sep 30 2021 and $ -21.9 millions from the TTM period ending Sep 30 2021 Sofia Sousa wrote.

Immunic Inc achieved highest trailing twelve month year on year Income from Cont. Operations growth. While overall Income from Cont. Operations growth ranking, remained unchanged compare to the previous quarter at no. .

Income from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Income from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Income from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Income from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Income from Cont. Operations Growth
Major Pharmaceutical Preparations Industry Income from Cont. Operations Growth Trends and Statistics
Healthcare Sector Income from Cont. Operations Growth Statistics
Income from Cont. Operations Growth Trends for overall market
IMUX's Income from Cont. Operations Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Income from Cont. Operations Growth
Lowest Ranking Income from Cont. Operations Growth
Income from Cont. Operations Growth for IMUX's Competitors
Income from Cont. Operations Growth for Immunic Inc 's Suppliers
Income from Cont. Operations Growth for IMUX's Customers

You may also want to know
IMUX's Annual Growth Rates IMUX's Profitability Ratios IMUX's Asset Turnover Ratio IMUX's Dividend Growth
IMUX's Roe IMUX's Valuation Ratios IMUX's Financial Strength Ratios IMUX's Dividend Payout Ratio
IMUX's Roa IMUX's Inventory Turnover Ratio IMUX's Growth Rates IMUX's Dividend Comparisons



Companies with similar Income from Cont. Operations no change for the quarter ending Sep 30 2022 within Healthcare SectorY/Y Change %Income from Cont. Operations for the quarter ending Sep 30 2022
Ensign Group Inc16.34%$ 16.337 millions
Integra Lifesciences Holdings Corp15.47%$ 15.466 millions
Amgen Inc 13.75%$ 13.747 millions
Viatris Inc 13.74%$ 13.740 millions
Corcept Therapeutics Inc13.39%$ 13.386 millions
Prestige Consumer Healthcare Inc 12.06%$ 12.063 millions
Assertio Holdings inc 11.69%$ 11.694 millions
Syneos Health Inc 11.25%$ 11.255 millions
Option Care Health Inc 9.43%$ 9.435 millions
Vertex Pharmaceuticals Inc9.22%$ 9.223 millions
Iqvia Holdings Inc 8.43%$ 8.429 millions
Mettler Toledo International Inc8.30%$ 8.301 millions
Acadia Healthcare Company Inc 7.58%$ 7.579 millions
Atrion Corporation6.79%$ 6.790 millions
Avantor Inc 6.51%$ 6.505 millions


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

SPIN's Profile

Stock Price

SPIN's Financials

Business Description

Fundamentals

Charts & Quotes

SPIN's News

Suppliers

SPIN's Competitors

Customers & Markets

Economic Indicators

SPIN's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071